Chemical Market Reporter: February 2006

NanoHorizons Inc, which is based at State College, PA, has received $2.2 M in capital investment. The company produces antimicrobial silver nanoparticles for textile applications.


Chemical Market Reporter: February 2006

Pure Bioscience reported Revenues for 1Q 2005-2006 at $55,200 ($25,500 in 1Q 2004-2005). The company reported a loss of $609,500 for 1Q 2005-2006 (loss of $632,900 in 1Q 2004-2005). Research and development expenses for the 1Q 2005-2006 were $248,969 ($283,256 in 1Q 2004-2005). Pure Bioscience develops and markets technology-based bioscience products that provide non-toxic solutions to numerous global health challenges. Pure Bioscience's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials and boric acid-based pesticides, represent innovative advances in diverse markets.


Speciality Chemicals: February 2006

Microban, a producer of antimicrobial technology, is urging Britain's healthcare decision makers to pay more attention to the built environment when considering measures to reduce incidence of health care-associated infections (HAIs), such as MRSA. Today, Microban will launch a charter for healthcare building design. The charter advocates additional infection control measures that should become standard practice during construction or refurbishment of healthcare facilities. The risk of infection may be mitigated by building health care environment from Microban antimicrobial materials. Microban is a process that allows antimicrobial active ingredients to be incorporated directly into a polymer's molecular structure. Any product made from this polymer will have antimicrobial protection. This means that when used in conjunction with good hygiene practice, Microban works between cleanings to inhibit the growth of a broad spectrum, of bacteria, mould, mildew and fungi for the lifetime of the product. Non-polymer materials such as metal can easily be encapsulated in a Microban protected polymer "skin". Microban protection has proven effective via extensive lab testing and from use in both commercial and domestic environments. In the UK, when listeria and other dangerous food poisoning pathogens threatened public health, Microban was part of a series of effective steps that reduced cross contamination in the food production industry.


Chemical Week: February 2006

For full-year 2005, Arch’s profit more than doubled to $56.7m from 20.3m in 2004. Sales for the full-year 2005 increased 16% to $1.3bn over the full-year 2004.

“We benefited from strong results in performance urethanes and record demand for our biocides used in antidandruff shampoos and marine paints," said chairman, president and chief executive Michael Campbell. Arch said its biocides portfolio strengthened with the purchase of the remaining 50% share of its water products joint venture, Nordesclor, in Brazil. For 2006, Arch said operating margins for its HTH water products business was expected to be in the 7-8% range.


European Chemical News: February 2006

International Specialty Products Inc. (ISP), has signed an agreement to acquire the assets of the biocide business of Milker & Grüning GmbH (M&G). The transaction, which is expected to close in the second quarter, is subject to customary closing conditions. M&G, located outside of Frankfurt, Germany, is a manufacturer of iodopropynyl butylcarbamate (IPBC), a preservative for paints and coatings. Sunil Kumar, ISP's President and CEO stated: “Through this acquisition, ISP gains access to a low-cost source of high quality product, providing us with a significant advantage in the global biocides market.” Pieter Steenbeek, Business Director Biocides Europe, also commented on the transaction: “IPBC is a strategic active for ISP’s existing biocide formulations business and will further enhance ISP’s preservative offerings.”